Skip Navigation

Impact of rapid diagnostic tests: failure of implementation or intervention?

Read the Cochrane review commentary from ACT Consortium members Clare Chandler and Christopher Whitty in the International Journal of Epidemiology.

Malaria research publications

Browse through more than 60 journal articles published by ACT Consortium investigators on the access, targeting, safety and quality of antimalarials.

Our research themes

We do research to improve access and targeting, and assess the quality and safety of artemisinin-based combination treatment (ACT), the WHO recommended first-line treatment for malaria.

Videos of our research projects

Our revamped website includes videos with ACT Consortium investigators talking about their studies on the access, targeting, quality and safety of ACT drugs.

View all ACT Consortium news

The ACT Consortium is an international research collaboration formed in November 2007 to answer key questions on malaria drug delivery in Africa and Asia.  

Our goal is to develop and evaluate delivery mechanisms to improve ACT access, targeting, safety and quality. 

The ACT Consortium is funded by the Bill & Melinda Gates Foundation and has partners throughout Africa, Asia, Europe and the United States.  It is coordinated through the London School of Hygiene & Tropical Medicine.